Advanced Search | View Cart | Check Out | 800.284.8433
Bookmark and Share

Nuclear Oncology

The Johns Hopkins University School of Medicine
Genetic alterations often indicate the risk of developing cancer and can define molecular signatures suitable for radionuclide diagnosis and therapy. Once identified, they can be targets for stable or radioactive pharmaceuticals to try to bring about complete or partial remission of the patient’s disease. This program in Nuclear Oncology covers imaging, dosimetric, and therapeutic applications of radiopharmaceuticals and metabolic imaging agents, with descriptions of how these techniques are being applied in the care of patients. The integration of imaging to personalized treatment choices is also emphasized.
 
CREDITS Earn 9.70 AMA PRA Category 1 Credit(s)
CE RELEASE July 15, 2008
CE EXPIRE June 15, 2011
 
Item No Media (Can't decide on a format?) Price Purchase
625DD
Video - DVD: Includes 5 DVDs with carrying case, a comprehensive course syllabus on CD-ROM, and a program evaluation
$345.00
625AUP
Additional User Package: Each AUP includes a comprehensive syllabus on CD-ROM and a CME credit package (initial video purchase required).
$125.00
 
Special pricing for clinic-wide orders or for group subscriptions/purchases. Minimum order quantities apply for eligible discounts. For further information and pricing estimates, contact Kyle Jackson at 1-800-952-0690 x3075.
 

Target Audience


This program will have special relevance for nuclear medicine physicians, radiologists, and radiation oncologists,
and will also be useful for all who treat patients with cancer.

 
 

Topics & Speakers


From Molecular Imaging to Molecular Medicine
Henry N. Wagner, Jr., MD

The Role of Genes in Cancer
Will Parsons, MD, PhD

The Radiobiology of Cancer Therapy
Fred Bunz, MD, PhD

LymphomaRadioimmunotherapy: Last Resort or First Choice
Mark S. Kaminski, MD

PET/CT to Plan Therapy
Yvette L. Kasamon, MD

SPECT/CT to Plan Therapy
Richard L. Wahl, MD

Quantitative Data from SPECT/CT
Benjamin M. W. Tsui, PhD

Thyroid CancerUpdate on Dosimetry-Based Techniques
George Sgouros, PhD

Molecular Basis for Thyroidal Radioiodine Avidity and Its Loss in Thyroid Cancer Cells
Paul W. Ladenson, MD

Neuroendocrine TumorsExperience with MIBG
Alexander J.B. McEwan, MD

Radiopeptides as Therapeutic Agents
Otto C. Boerman, PhD

Solid Tumors90Y-Microspheres for Liver Tumors
Jeff H. Geschwind, MD

RIT for Pancreatic Cancer
David M. Goldenberg, SCD, MD

RIT for Colon and Renal Cancers
Chaitanya R. Divgi, MD

Early Experience Using Peptide Targeted Radionuclide Therapy in Patients with Lung Cancer
John Lister-James, PhD

Control of the Expression of the Genotype
Stephen B. Baylin, MD

Brain Tumors, Sarcoma, and Bone Metastase 131I-Scorpion Venom Toxin for Treatment of Brain Tumors
Heather A. Jacene, MD

Sarcoma
David M. Loeb, MD, PhD

Metastatic Bone Disease
Alexander J.B. McEwan, MD

Therapy with Alpha ParticlesDosimetry
George Sgouros, PhD

Experience with Radium-223 in the Treatment of Patients with Skeletal Metastases
Peter A. Harris, MBBS, FFPM

Actinium-225 and Bismuth-213 for Leukemia
David A. Scheinberg, MD, PhD

Astatine-211 Labeled Radiopharmaceuticals
Ganesan Vaidyanathan, PhD

Prospects for the FutureTranslating Radiopharmaceuticals from the Laboratory to the Clinic
George Q. Mills, MD

Pretargeting with Bispecific Antibodies
Otto C. Boerman, PhD

New Ligands and Approaches to Radionuclide Imaging and Therapy
Martin G. Pomper, MD, PhD

Integration of Radionuclide Therapy into Multidisciplinary Treatment of Solid Tumors
Chaitanya R. Divgi, MD




Course Director

Richard L. Wahl, MD
Professor of Radiology and
Radiological Science and of Oncology
Henry N. Wagner, Jr. Professor of Nuclear Medicine
Director, Division of Nuclear Medicine / PET
The Johns Hopkins University School of Medicine
   

Guest Faculty

Otto C. Boerman, PhD
Professor Radiochemistry
Radboud University Nijmegen Medical Centre
Department of Nuclear Medicine
Nijmegen, The Netherlands

Chaitanya R. Divgi, MD
Professor of Radiology and Radiation Oncology
Professor, Wistar Institute
Member, Abramson Cancer Center
University of Pennsylvania
Chief, Division of Nuclear Medicine
and Clinical Molecular Imaging
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania

David M. Goldenberg, SCD, MD
President of the Garden State Cancer Center and the Center for Molecular Medicine and Immunology
Belleville, New Jersey

Peter A. Harris, MBBS, FFPM
Chief Medical Officer, Algeta ASA
Oslo, Norway

Mark S. Kaminski, MD
Professor of Internal Medicine
Division of Hematology/Oncology
Director, Leukemia/Lymphoma Program
Director, Multidisciplinary Lymphoma Clinic
University of Michigan Comprehensive Cancer Center
Ann Arbor, Michigan

John Lister-James, PhD
Vice President, Development
Xanthus Pharmaceuticals, Inc.
Cambridge, Massachusetts

Alexander J.B. McEwan, MD
Director of Oncologic Imaging
Cross Cancer Institute
Edmonton, Canada

George Q. Mills, MD
Vice President, Perceptive Informatics
Medical Imaging Consulting
Washington, DC

David A. Scheinberg, MD, PhD
Chairman, Molecular Pharmacology and Chemistry Program
Experimental Therapeutics Center
Memorial Sloan Kettering Cancer Center
New York, New York

Ganesan Vaidyanathan, PhD
Professor of Radiology
Faculty, Medical Physics Graduate Program
Duke University Medical Center
Durham, North Carolina

Johns Hopkins Faculty

Stephen B. Baylin, MD
Professor of Oncology

Fred Bunz, MD, PhD
Associate Professor of Radiation Oncology

Jeff F. Geschwind, MD
Associate Professor of Radiology and Radiological Science, of Surgery and of Oncology
Director, Vascular and Interventional Radiology

Heather A. Jacene, MD
Assistant Professor of Radiology and Radiological Science and of Nuclear Medicine

Yvette L. Kasamon, MD
Assistant Professor of Oncology and of Medicine

Paul W. Ladenson, MD
Professor of Medicine
Division of Endocrinology

David M. Loeb, MD, PhD
Assistant Professor of Oncology and of Pediatrics
Director, Musculoskeletal Tumor Program

Will Parsons, MD, PhD
Instructor in Pediatrics
Division of Oncology

Martin G. Pomper, MD, PhD
Professor of Radiology and Radiological Science

George Sgouros, PhD
Professor of Radiology and Radiological Science

Benjamin M. W. Tsui, PhD
Professor of Radiology and Radiological Science, of Electrical and Computer Engineering, of Environmental Health Sciences
and of Biomedical Engineering
Director, Division of Medical Imaging Physics

Henry N. Wagner, Jr., MD
Professor Emeritus of Medicine and of Radiology and Radiological Science
The Johns Hopkins University School of Medicine
Professor of Environmental Health Sciences
Director, Division of Radiation Health Sciences
Johns Hopkins Bloomberg School of Public Health



 
 

Learning Objectives


At the conclusion of this program, participants should be able to:
  • Improve their ability to treat patients with Lymphoma
  • Select appropriate therapy for a variety of tumors
  • Describe particular advantages of alpha therapy
  • Describe current and future directions of research

 
 

Accreditation Statement


The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
 
 

Credit Designation Statement


The Johns Hopkins University School of Medicine designates this educational activity for a maximum of 9.70 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
 
 

Policy on Speaker and Provider Disclosure


It is the policy of The Johns Hopkins University School of Medicine that the speaker and provider disclose real or apparent conflicts of interest relating to the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s). The Johns Hopkins University School of Medicine OCME has established policies in place that will identify and resolve all conflicts of interest prior to this educational activity. Detailed disclosure will be made in the activity electronic syllabus. The Johns Hopkins University School of Medicine takes responsibility for the content, quality, and scientific integrity of this CME activity.

Release date: July 15, 2008
Credits expire: June 15, 2011

CME credit is obtained upon successful completion of an activity evaluation. A $35 processing fee must accompany the completed evaluation application.